Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099006 · ClinicalTrials.gov registry record · Phase 2
Novel Topical Therapies for the Treatment of Genital Pain
A Phase 2 study of Female Genital Diseases, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT02099006: Completed Phase 2 study of Female Genital Diseases, sponsored by University of Rochester.
NCT02099006 is a Phase 2 study of Female Genital Diseases that has completed, run by University of Rochester. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02099006, a Phase 2 study of Female Genital Diseases, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning.
Primary Outcome
Each subject was asked to keep a symptom diary recording her daily genital pain, measured on a 10 point Likert scale. A score of "0" was defined as no pain and a score of "10" was defined as worst imaginable pain. These daily values were collected and a mean pain score for the period of treatment was calculated.
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Amitriptyline
- DRUG Loperamide
- DRUG Baclofen
- DRUG Ketoprofen
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
What the finished NCT02099006 record still lists
NCT02099006 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Female Genital Diseases appearing as the primary indexed condition, and to 5 interventions - of which Ketamine is the first listed.
NCT02099006 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02099006 about?
NCT02099006 is a clinical study titled "Novel Topical Therapies for the Treatment of Genital Pain". This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning.
What is the current status of trial NCT02099006?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2013-11. Estimated completion is 2015-06.
What conditions does trial NCT02099006 study?
This clinical trial studies the following conditions: Female Genital Diseases.
What interventions are being tested in trial NCT02099006?
The interventions under investigation include: Ketamine (DRUG), Amitriptyline (DRUG), Loperamide (DRUG), Baclofen (DRUG), Ketoprofen (DRUG).
Who is sponsoring clinical trial NCT02099006?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02099006 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02099006's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia